Allarity Therapeutics (ALLR)

• Market cap: $13.6M
• 1 day: -6.08%
• 5 days: 3.09%
• 1 month: -25.85%
• 3 months: -33.44%
• 6 months: -11.94%
• Year to date: -25.85%
• 1 year: -16.31%
• 5 years: -100%
• 10 years: -100%
• Sector: Healthcare
• Industry: Biotechnology

About: Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Employees: 7